SEC Form 4 · accession 0001209191-17-030121
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Virinder Nohria
Director
Period of report
May 3, 2017
Accepted (ET)
May 4, 2017 · 6:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | May 3, 2017 | M | 13,953 | — | A | 19,211 | I | By Trust |
| Ordinary Shares | holding | — | — | — | 189,836 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | May 3, 2017 | M | 13,953 | D | — | — | Ordinary shares | 13,953 | 0 | D |
| Stock Option (Right to Buy)F3 | $15.12 | May 3, 2017 | A | 31,153 | A | — | May 2, 2027 | Ordinary shares | 31,153 | 31,153 | D |
| Restricted Stock UnitsF1 | — | May 3, 2017 | A | 14,054 | A | May 3, 2018 | — | Ordinary shares | 14,054 | 14,054 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- F2On May 3, 2016, the reporting person was granted 13,953 restricted stock units, vesting in full on the first anniversary of the grant date.
- F3The option vests in 12 equal monthly installments from the date of grant.